Last edition
News about Global Pharma
Pint Pharma Gets ANVISA Approval of BESREMi for Polycythemia Vera
Polycythemia Vera (PV) is a rare, chronic, debilitating, and potentially fatal myeloproliferative neoplasm, originating from a disease-initiating stem cell in the bone marrow.
Global Pharma | 21/03/2025 | By Aishwarya | 584
Grifols and Inpeco to Deliver Transfusion Medicine Labs
Grifols, whose technology analyzes tens of millions of donor samples each year, now complements its portfolio with Inpeco’s new open automation system FlexLab™ X, a combination of leading-edge robotics and software that will enable Grifols solutions to interconnect with, and expand within, existing and future lab footprints.
Global Pharma | 21/03/2025 | By Aishwarya | 244
Advanced Instruments Plans to Acquire and Merge Nova Biomedical
Following the closing of the transaction, Advanced Instruments and Nova Biomedical will merge, creating a global life science tools platform that will operate under the Nova Biomedical name, with a diversified portfolio of analytical instruments, reagents and services.
Global Pharma | 20/03/2025 | By Aishwarya | 339
Supriya Lifescience Inaugurates New 5 MWp Solar Facility in Maharashtra
This initiative is part of the ongoing program in which Supriya Lifesciences is committed to reducing carbon footprint from its operations.
Global Pharma | 20/03/2025 | By Aishwarya | 575
Indegene Inaugurates New Center in London to Expand Globally
Indegene’s Europe-based clients can now benefit from this center as a strategic hub for consulting and commercialization solutions and modernize their operations with an AI-first approach.
Global Pharma | 20/03/2025 | By Aishwarya | 355
Marksans Pharma’s UK subsidiary Relonchem has received UK MHRA approval for Baclofen 10 mg tablets, strengthening its presence in the UK pharmaceutical market.
Global Pharma | 19/03/2025 | By Manvi | 829
Kincell Bio Welcomes Larry Pitcher as Chief Operating Officer
Most recently, Larry was VP and GM for Catalent’s Gene Therapy Sites in MD, their largest operation, which accounted for a significant share of the company’s annual revenue.
Global Pharma | 19/03/2025 | By Aishwarya | 224
Shilpa Biologicals, mAbTree Biologics to Develop Immuno-Oncology Therapy
Under the terms of the agreement, Shilpa Biologicals will support the entire development process, including first-in-human clinical trials, while also ensuring long-term commercial supply through its Good Manufacturing Practice (GMP) manufacturing capabilities.
Global Pharma | 19/03/2025 | By Aishwarya | 630
Delpharm to Advance its Sterile Injectable Manufacturing Facility in Boucherville
The signing of a 10-year agreement between Delpharm and Sandoz establishes a foundation for ensuring a stable and reliable supply of critical medicines for Canadians, thereby enhancing the country's healthcare autonomy amid global supply chain disruptions.
Global Pharma | 19/03/2025 | By Aishwarya | 317
TAF 2025 Calls for Stricter Laws to Curb Drug Counterfeiting
In a major push to protect India’s industries, stakeholders at the 6th edition of the Traceability and Authentication Forum (TAF 2025) called for stricter anti-counterfeiting laws and advanced traceability measures.
Global Pharma | 19/03/2025 | By Aishwarya | 310
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy